Literature DB >> 6841587

Characterization of the hemolytic activity of Staphylococcus aureus strains associated with toxic shock syndrome.

A W Chow, M J Gribble, K H Bartlett.   

Abstract

The hemolytic activity of 32 vaginal isolates of Staphylococcus aureus from patients with typical toxic shock syndrome (TSS) was contrasted with that of 50 vaginal isolates from patients without TSS, using a standardized inoculum (10(5) CFU) on 5% sheep blood agar after 48 h of incubation under 30% CO2. Additionally, 7 nongenital isolates from patients with nonmenstrual TSS and 57 strains of nongenital control isolates were included for comparison. Vaginal TSS strains were significantly less hemolytic than non-TSS S. aureus strains of either genital (P less than 0.001) or nongenital (P less than 0.01) origin. Vaginal TSS S. aureus strains were also less hemolytic than were nongenital TSS S. aureus strains (P less than 0.02). This reduced hemolytic activity of genital TSS S. aureus strains may provide a useful marker for screening and further delineation of toxigenic S. aureus associated with menstrually related TSS.

Entities:  

Mesh:

Year:  1983        PMID: 6841587      PMCID: PMC272679          DOI: 10.1128/jcm.17.3.524-528.1983

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  15 in total

Review 1.  The hemolysins of Staphylococcus aureus.

Authors:  G M Wiseman
Journal:  Bacteriol Rev       Date:  1975-12

Review 2.  Nonenteric toxins of Staphylococcus aureus.

Authors:  M Rogolsky
Journal:  Microbiol Rev       Date:  1979-09

3.  Distribution of haemolysins in pathogenic and non-pathogenic staphylococci.

Authors:  S D ELEK; E LEVY
Journal:  J Pathol Bacteriol       Date:  1950-10

4.  Epidermal toxin production by Staphylococcus aureus strains from patients with toxic shock syndrome.

Authors:  F A Kapral
Journal:  Ann Intern Med       Date:  1982-06       Impact factor: 25.391

5.  Identification and characterization of an exotoxin from Staphylococcus aureus associated with toxic-shock syndrome.

Authors:  P M Schlievert; K N Shands; B B Dan; G P Schmid; R D Nishimura
Journal:  J Infect Dis       Date:  1981-04       Impact factor: 5.226

6.  Toxic shock syndrome in menstruating women.

Authors:  R F Fisher; H C Goodpasture; J D Peterie; D W Voth
Journal:  Ann Intern Med       Date:  1981-02       Impact factor: 25.391

7.  Toxic-shock syndrome associated with phage-group-I Staphylococci.

Authors:  J Todd; M Fishaut; F Kapral; T Welch
Journal:  Lancet       Date:  1978-11-25       Impact factor: 79.321

8.  Toxic shock syndrome: clinical and laboratory features in 15 patients.

Authors:  R W Tofte; D N Williams
Journal:  Ann Intern Med       Date:  1981-02       Impact factor: 25.391

9.  Staphylococcus aureus associated with toxic shock syndrome: phage typing and toxin capability testing.

Authors:  W A Altemeier; S A Lewis; P M Schlievert; M S Bergdoll; H S Bjornson; J L Staneck; B A Crass
Journal:  Ann Intern Med       Date:  1982-06       Impact factor: 25.391

10.  Vaginal isolates of Staphylococcus aureus associated with toxic shock syndrome.

Authors:  A G Barbour
Journal:  Infect Immun       Date:  1981-08       Impact factor: 3.441

View more
  8 in total

1.  Regulation of Staphylococcus aureus type 5 and type 8 capsular polysaccharides by CO(2).

Authors:  S Herbert; S W Newell; C Lee; K P Wieland; B Dassy; J M Fournier; C Wolz; G Döring
Journal:  J Bacteriol       Date:  2001-08       Impact factor: 3.490

2.  Production of gamma-hemolysin and lack of production of alpha-hemolysin by Staphylococcus aureus strains associated with toxic shock syndrome.

Authors:  M Clyne; J De Azavedo; E Carlson; J Arbuthnott
Journal:  J Clin Microbiol       Date:  1988-03       Impact factor: 5.948

3.  Characterization of staphylococci from patients with toxic shock syndrome.

Authors:  B Aliu; M S Bergdoll
Journal:  J Clin Microbiol       Date:  1988-11       Impact factor: 5.948

4.  The amino acid sequence of a gonococcal growth inhibitor from Staphylococcus haemolyticus.

Authors:  D C Watson; M Yaguchi; J G Bisaillon; R Beaudet; R Morosoli
Journal:  Biochem J       Date:  1988-05-15       Impact factor: 3.857

5.  Chemical and biological characterization of a gonococcal growth inhibitor produced by Staphylococcus haemolyticus isolated from urogenital flora.

Authors:  M Frenette; R Beaudet; J G Bisaillon; M Sylvestre; V Portelance
Journal:  Infect Immun       Date:  1984-11       Impact factor: 3.441

Review 6.  Toxic-shock syndrome: a commentary and review of the characteristics of Staphylococcus aureus strains.

Authors:  P J Chesney
Journal:  Infection       Date:  1983 Jul-Aug       Impact factor: 3.553

7.  Effect of strain of Staphylococcus aureus on synergism with Candida albicans resulting in mouse mortality and morbidity.

Authors:  E Carlson
Journal:  Infect Immun       Date:  1983-10       Impact factor: 3.441

8.  Genotypic and phenotypic analysis of clinical isolates of Staphylococcus aureus revealed production patterns and hemolytic potentials unlinked to gene profiles and source.

Authors:  Andreas Roetzer; Guenter Haller; John Beyerly; Christoph B Geier; Hermann M Wolf; Corina S Gruener; Nina Model; Martha M Eibl
Journal:  BMC Microbiol       Date:  2016-02-01       Impact factor: 3.605

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.